FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05% | Optometry Times - Clinical News

Published on December 2, 2025
Cyclosporine ophthalmic emulsion 0.05% is a topical immunomodulator to increase tear production in patients whose tear production is thought to be reduced due to ocular inflammation associated with dry eye syndrome.
Continue reading on website
Other news

Low Retinal Vascular Complexity May Flag Higher Cardiovascular Risk

December 2, 2025
This research investigates the relationship between retinal microvascular complexity and cardiovascular health, highlighting how changes in retinal vessel patterns, measured by fractal dimension, could serve as noninvasive indicators of cardiovascular outcomes. The above images (from a different study) show the difference between high (top image) and low (bottom image) fractal dimension. Photo: Ch

The Vision Council Spotlights Key Optical Trends in Market inSights Q3 2025 Report

December 3, 2025
ALEXANDRIA, Va.—The Vision Council announced it has released its Market inSights Q3 2025 report, presenting new market data and analysis that details the performance of the $17.5 billion optical industry.  The report examines trends across key categories such as eye exams, eyeglasses, frames, lenses, contact lenses, readers and plano sunglasses. For the third quarter of 2025, the report revealed d